Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Multiple Myeloma 2Glioma 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Pain 1Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Magnetic Resonance Imaging 1Kidney Neoplasms 1Hypothyroidism 1Hyperphagia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Goiter 1Glioblastoma 1Emergencies 1Critical Illness 1Carcinoma, Renal Cell 1Cancer Pain 1Breast Neoplasms 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glioma × Glucose × Clear all
NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Stanford University

Phase 2 Suspended
10 enrolled
CNS

Glioma

NCT06594315 2025-09-18

Assessing Brain Metabolism Using MRS With Deuterated Glucose

University of California, San Francisco

Active not recruiting
80 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡